Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of TERUMO CORPORATION. A complete text table follows the diagram.
Blood & Cell Technologies Company is the next-largest disclosed stream in the latest EDINET half-year filing.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Cardiac and Vascular Company | 1 | 322.1B | 60.2% of reported total |
| Blood & Cell Technologies Company | 1 | 107.1B | 20.0% of reported total |
| Medical Care Solutions Company | 1 | 105.6B | 19.7% of reported total |
| Reconciling Items | 1 | 163M | 0.0% of reported total |
| Other & rounding | 1 | 1M | 0.0% of reported total |
| External customer revenue | 2 | 534.9B | Reported six-month total · ¥534.9B |
| Operating profit | 3 | 101.0B | 18.9% operating margin |
| Operating costs & expenses | 3 | 433.9B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 101.2B | Reported pretax result |
| Net non-operating income | 3 | 229M | Arithmetic bridge to reported pretax profit |
| Net profit attributable to owners | 5 | 76.9B | Reported parent-company result |
| Tax, attribution & other | 5 | 24.3B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Cardiac and Vascular Company | External customer revenue | 322.1B |
| Blood & Cell Technologies Company | External customer revenue | 107.1B |
| Medical Care Solutions Company | External customer revenue | 105.6B |
| Reconciling Items | External customer revenue | 163M |
| Other & rounding | External customer revenue | 1M |
| External customer revenue | Operating profit | 101.0B |
| External customer revenue | Operating costs & expenses | 433.9B |
| Operating profit | Profit before tax | 101.0B |
| Net non-operating income | Profit before tax | 229M |
| Profit before tax | Net profit attributable to owners | 76.9B |
| Profit before tax | Tax, attribution & other | 24.3B |